Free Trial
NASDAQ:OKUR

OnKure Therapeutics 11/7/2024 Earnings Report

OnKure Therapeutics logo
$2.18 +0.02 (+0.93%)
As of 09:30 AM Eastern

OnKure Therapeutics EPS Results

Actual EPS
-$1.10
Consensus EPS
-$0.97
Beat/Miss
Missed by -$0.13
One Year Ago EPS
N/A

OnKure Therapeutics Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

OnKure Therapeutics Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

OnKure Therapeutics Earnings Headlines

Altucher: Turn $900 into $108,000 in just 12 months?
We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.
OnKure Therapeutics (OKUR) to Release Earnings on Tuesday
See More OnKure Therapeutics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like OnKure Therapeutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on OnKure Therapeutics and other key companies, straight to your email.

About OnKure Therapeutics

OnKure Therapeutics (NASDAQ:OKUR), Inc. engages in discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. The company uses a structure and computational chemistry driven drug design platform, committed to improving clinical outcomes for patients by building a robust pipeline of small molecule drugs designed to selectively target specific mutations thought to be key drivers of cancer. It is headquartered in Boulder, CO.

View OnKure Therapeutics Profile

More Earnings Resources from MarketBeat